My oncologist has one of those little motivational prints hanging on his waiting room wall, with the simple statement: "trust your instincts." One day, bored with the long purgatory of the waiting room, I tweet this news ...
Aug 4, 2022
0
16
Researchers at the Vancouver Prostate Center have developed a new blood test that provides unprecedented insight into a patient's cancer make-up, potentially allowing doctors to better select treatment options that will improve ...
Jul 20, 2022
0
1924
Hormone therapy is successful at keeping metastatic prostate cancer under control, but eventually the tumor cells become resistant to it. An unexpected potential solution has now emerged in medicines not designed to fight ...
Jun 27, 2022
0
79
As the cost of genome and exome sequencing falls, its use in characterizing rare diseases and personalizing cancer treatment, for example, is becoming far more frequent. But such analyses may throw up findings unrelated to ...
Jun 10, 2022
0
17
Researchers at the University of Bern and University Hospital Bern have achieved a breakthrough in a particularly aggressive form of prostate cancer. In tissue samples from advanced brain metastases, they were able to establish ...
May 12, 2022
0
70
Hormone therapy is often used to treat prostate cancer that has spread to other parts of the body, but many patients develop resistance to hormone therapy, causing their disease to become more aggressive and potentially more ...
May 10, 2022
0
34
Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with low-grade prostate ...
Apr 22, 2022
0
19
A new study from Keck Medicine of USC finds that the incidence rate of metastatic prostate cancer has significantly increased for men 45 and older and coincides with recommendations against routine prostate cancer screenings.
Mar 14, 2022
0
68
Results from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding the androgen-receptor inhibitor darolutamide to androgen-deprivation therapy and chemotherapy prolongs ...
Feb 18, 2022
0
79
(HealthDay)—There were large temporal changes in screening, biopsy, overall cancer detection, and metastatic cancer rates following the 2012 U.S. Preventive Services Task Force (USPSTF) Prostate Cancer Screening Statement, ...
Dec 22, 2021
0
5
